February 16, 2022
German Federal Court of Justice upholds AOP’s license rights in Ropeginterferon and PEC’s liability for damages
AOP Orphan Pharmaceuticals announced that on Monday February 14, 2022 the German Federal Court of Justice decided on PEC’s challenge…